# OnCo record ts-p04834 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/ts-p04834/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "ts-p04834", "NCT01500226" ;
  schema:name "Study 3 (rolapitant, moderately emetogenic chemotherapy)"@en ;
  schema:alternateName "Study 3"@en, "TS-P04834"@en, "TS P04834"@en ;
  schema:description "Study 3 showed that a long-lasting anti-sickness tablet, rolapitant, taken once before moderately strong chemotherapy kept more people free of vomiting and rescue medicine in the days after treatment than the usual anti-sickness pair alone; it was one of the three trials behind the US approval of Varubi."@en ;
  schema:url <https://onco.cc/trials/ts-p04834/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01500226>, <https://doi.org/10.1016/S1470-2045(15)00034-0>, <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8670c3cf-82d9-466d-be49-de33d8c8742b> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:sections <https://onco.cc/fronts/supportive-care/> ;
  onco:drugs <https://onco.cc/drugs/rolapitant/>, <https://onco.cc/drugs/granisetron/>, <https://onco.cc/drugs/dexamethasone/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-rolapitant-study-3-schwartzberg-lancet-oncol-2015/> .